Equities researchers at Canaccord Genuity boosted their target price on shares of Vital Therapies (NYSE:VTL) from $20.00 to $35.00 in a research report issued on Friday.  Vital Therapies, Inc. (NASDAQ:VTL) belongs to Healthcare sector. Its weekly performance is 12.21%. On last trading day company shares ended up $25.00. Vital Therapies, Inc. (NASDAQ:VTL) distance from 50-day simple moving average (SMA50) is -2.15%. Maxim Integrated Products (NASDAQ:MXIM) was downgraded by … Continue reading Stocks to Watch : Vital Therapies (NASDAQ:VTL), Maxim Integrated Products (NASDAQ:MXIM), Acura Pharmaceuticals (NASDAQ:ACUR), Oceaneering International, (NYSE:OII), Dominion Resources (NYSE:DOM)